Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?


TOPUK S. , Akyuva Y., Karaaslan N., Mutlu C. A. , Yilmaz I., Isyar M., ...Daha Fazla

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, cilt.18, ss.516-522, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 18 Konu: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.2174/1389201018666170615083455
  • Dergi Adı: CURRENT PHARMACEUTICAL BIOTECHNOLOGY
  • Sayfa Sayıları: ss.516-522

Özet

Purpose: The present study aimed to analyze the researches that are at the experimental phase concerning osteosarcoma treatment. The researches included drug delivery systems which allow controlled release and imbue small interfering-/micro-ribonucleic acid.